AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism.
Market Cap | 257.579 Billion | Shares Outstanding | 1.768 Billion | Avg 30-day Volume | 5.874 Million |
P/E Ratio | 17.5995 | Dividend Yield | 4.1623 | EPS | 1.3 |
Price to Revenue | 4.0809 | Debt to Equity | 4.343 | EBITDA | 25.211 Billion |
Price to Book Value | 14.7528 | Operating Margin | 30.593700000000002 | Enterprise Value | 293.481 Billion |
Current Ratio | 0.928 | EPS Growth | 0.845 | Quick Ratio | 0.692 |
1 Yr BETA | 0.3533 | 52-week High/Low | 169.46 / 128.17 | Profit Margin | 23.2069 |
Operating Cash Flow Growth | 0.1507 | Altman Z-Score | 1.9633 | Free Cash Flow to Firm | 24.314 Billion |
Please sign in first
none
42.4 Thousand total shares from 2 transactions
42.4 Thousand total shares from 1 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
23,256 | 2022-12-31 | 5 | |
|
8,723 | 2022-12-31 | 5 | |
RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER |
|
13,837 | 2022-12-12 | 3 |
SIATIS PERRY C EVP, GC AND SECRETARY |
|
10,377 | 2022-10-17 | 1 |
REENTS SCOTT T SVP, CHIEF FINANCIAL OFFICER |
|
809 | 2022-06-28 | 1 |
SEVERINO MICHAEL VICE CHAIRMAN |
|
233,769 | 2022-05-23 | 5 |
GOSEBRUCH HENRY O EVP, CHIEF STRATEGY OFFICER |
|
98,580 | 2022-05-16 | 6 |
STROM CARRIE C SVP & PRES GLOBAL ALLERG AESTH |
|
40,663 | 2022-05-11 | 7 |
|
50,705 | 2022-05-06 | 1 | |
|
47,939 | 2022-05-06 | 1 | |
|
24,983 | 2022-05-06 | 1 | |
|
128,717 | 2022-05-06 | 1 | |
|
9,753 | 2022-05-06 | 1 | |
|
15,497 | 2022-05-06 | 1 | |
|
22,983 | 2022-05-06 | 1 | |
|
12,523 | 2022-05-06 | 1 | |
|
28,474 | 2022-03-31 | 1 | |
STEWART JEFFREY RYAN EVP, CHIEF COMMERCIAL OFFICER |
|
62,279 | 2022-03-24 | 3 |
DURKIN BRIAN L VP, CONTROLLER |
|
19,094 | 2022-03-09 | 3 |
GONZALEZ RICHARD A CHAIRMAN OF THE BOARD AND CEO |
|
526,768 | 2022-02-25 | 2 |
SCHUMACHER LAURA J VICE CHAIRMAN |
|
248,002 | 2022-02-25 | 2 |
SALEKI-GERHARDT AZITA EVP, OPERATIONS |
|
164,107 | 2022-02-25 | 2 |
MICHAEL ROBERT A. VICE CHAIRMAN |
|
37,877 | 2022-02-25 | 2 |
HUDSON THOMAS J SVP, R&D AND CSO |
|
46,228 | 2022-02-25 | 2 |
SORG ELAINE K. SVP, US COMMERCIAL OPERATIONS |
|
17,876 | 2022-02-25 | 2 |
ALBAN CARLOS VICE CHAIRMAN |
|
155,341 | 2020-11-16 | 0 |
DONOGHOE NICHOLAS SVP, ENTERPRISE INNOVATION |
|
15,149 | 2020-02-28 | 0 |
CHASE WILLIAM J EVP, FINANCE & ADMINISTRATION |
|
170,053 | 2019-06-26 | 0 |
HURWICH THOMAS A. VP, CONTROLLER |
|
No longer subject to file | 2017-02-28 | 0 |
|
27,486 | 2015-05-08 | 0 | |
LEONARD JOHN M. SVP, CHIEF SCIENTIFIC OFFICER |
|
113,793 | 2013-03-15 | 0 |
|
0 | 2012-12-12 | 0 | |
|
0 | 2012-12-07 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-03 17:05:16 -0500 | 2022-12-31 | A | 239 | $161.61 | a | 23,256 | direct | |||||||||
2023-01-03 17:06:24 -0500 | 2022-12-31 | A | 46 | $161.61 | a | 8,723 | direct | |||||||||
2022-12-14 17:06:08 -0500 | 2022-12-12 | M | 42,370 | $54.86 | a | 56,207 | direct | -1.6064 | 0.1042 | 0.1042 | 6 | -1.6064 | 2 | |||
2022-12-14 17:06:08 -0500 | 2022-12-12 | S | 39,295 | $163.39 | d | 16,912 | direct | yes | -1.6064 | 0.1042 | 0.1042 | 6 | -1.6064 | 2 | ||
2022-12-14 17:06:08 -0500 | 2022-12-12 | S | 3,075 | $164.10 | d | 13,837 | direct | yes | -1.6064 | 0.1042 | 0.1042 | 6 | -1.6064 | 2 | ||
2022-12-14 17:06:08 -0500 | 2022-12-12 | M | 42,370 | d | 0 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ABBVIE INC ABBV | 2023-01-31 22:15:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 21:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 21:15:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 20:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 20:15:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 19:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 19:15:04 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 18:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 18:15:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 17:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 17:15:04 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 16:45:04 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 16:15:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 15:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 15:15:04 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 14:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 14:15:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 13:45:03 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 13:15:04 UTC | 4.07 | 0.25 | 0 |
ABBVIE INC ABBV | 2023-01-31 12:45:03 UTC | 4.07 | 0.25 | 0 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Highland Funds I- Highland Long/Short Equity Fund | ABBV | -6763.0 shares, $-515272.97 | 2020-03-31 | N-PORT |
FundVantage Trust- Gotham Master Neutral Fund | ABBV | -37.0 shares, $-3240.83 | 2020-09-30 | N-PORT |
VIVALDI OPPORTUNITIES FUND- Vivaldi Opportunities Fund | ABBV | -10598.0 shares, $-807461.62 | 2020-03-31 | N-PORT |
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | ABBV | -700.0 shares, $-93947.0 | 2022-09-30 | N-PORT |
GMO TRUST- GMO Benchmark-Free Fund | ABBV | -300.0 shares, $-48354.0 | 2022-11-30 | N-PORT |
Congress Person | Party | Chamber | Filing | Filing Date | Transaction Date | Security Type | Owner | Transaction | Amount | |
---|---|---|---|---|---|---|---|---|---|---|
![]() |
Hon. Rohit Khanna | democrat | House | Filing | 2022-12-02 | 2022-11-03 | SP | P | $1,001-$15,000 | |
![]() |
Hon. Rohit Khanna | democrat | House | Filing | 2022-11-02 | 2022-10-20 | DC | S | $1,001-$15,000 | |
![]() |
Hon. Rohit Khanna | democrat | House | Filing | 2022-11-02 | 2022-10-20 | DC | SP | $1,001-$15,000 | |
![]() |
Hon. Rohit Khanna | democrat | House | Filing | 2022-11-02 | 2022-10-20 | SP | S | $1,001-$15,000 | |
![]() |
Hon. Kathy Manning | democrat | House | Filing | 2022-10-04 | 2022-09-12 | SP | P | $1,001-$15,000 | |
![]() |
representative Rohit Khanna | democrat | House | Filing | 2022-09-08 | 2022-08-23 | SP | SP | $1,001-$15,000 | |
![]() |
representative Dwight Evans | democrat | House | Filing | 2022-08-16 | 2022-08-05 | P | $1,001-$15,000 | ||
![]() |
representative Kathy Manning | democrat | House | Filing | 2022-08-03 | 2022-07-27 | SP | SP | $1,001-$15,000 | |
![]() |
representative Kathy Manning | democrat | House | Filing | 2022-08-02 | 2022-07-15 | SP | P | $1,001-$15,000 | |
![]() |
representative Kathy Manning | democrat | House | Filing | 2022-08-02 | 2022-07-27 | SP | P | $1,001-$15,000 | |
![]() |
representative Kathy Manning | democrat | House | Filing | 2022-08-02 | 2022-07-27 | SP | $15,001-$50,000 |